why Genprex Inc [GNPX] is a Good Choice for Investors After New Price Target of $7.50

GFAI Stock

Genprex Inc [NASDAQ: GNPX] traded at a low on 2025-08-25, posting a -1.96 loss after which it closed the day’ session at $0.17.

The results of the trading session contributed to over 7059703 shares changing hands. Over the past one week, the price volatility of Genprex Inc stands at 14.66% while the volatility over the past one month is 11.00%.

The market cap for GNPX stock reached $5.52 million, with 33.15 million shares outstanding and 32.59 million shares in the current float. Compared to the average trading volume of 3.73M shares, GNPX reached a trading volume of 7059703 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Genprex Inc [GNPX]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GNPX shares is $7.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GNPX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

National Securities have made an estimate for Genprex Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 26, 2021. While these analysts kept the previous recommendation, Noble Capital Markets raised their target price to Outperform. The new note on the price target was released on April 29, 2019, representing the official price target for Genprex Inc stock.

The Price to Book ratio for the last quarter was 3.93, with the Price to Cash per share for the same quarter was set at 0.04.

How has GNPX stock performed recently?

Genprex Inc [GNPX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -13.57. With this latest performance, GNPX shares dropped by -39.43% in over the last four-week period, additionally sinking by -57.69% over the last 6 months – not to mention a drop of -80.62% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GNPX stock in for the last two-week period is set at 34.44, with the RSI for the last a single of trading hit 0.0250, and the three-weeks RSI is set at 0.0254 for Genprex Inc [GNPX]. The present Moving Average for the last 50 days of trading for this stock 0.2456, while it was recorded at 0.1620 for the last single week of trading, and 0.5141 for the last 200 days.

Genprex Inc (GNPX) Capital Structure & Debt Analysis

According to recent financial data for Genprex Inc. ( GNPX), the Return on Equity (ROE) stands at -602.64%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -331.39%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Genprex Inc’s Return on Invested Capital (ROIC) is -1262.44%, showcasing its effectiveness in deploying capital for earnings.

Genprex Inc (GNPX) Efficiency & Liquidity Metrics

Based on Genprex Inc’s (GNPX) latest financial statements, the Debt-to-Equity Ratio is 0.00%, indicating its reliance on debt financing relative to shareholder equity.

Genprex Inc (GNPX) Efficiency & Liquidity Metrics

From an operational efficiency perspective, Genprex Inc. (GNPX) effectively leverages its workforce, generating an average of -$1170666.67 per employee. The company’s liquidity position is robust, with a Current Ratio of 0.84% and a Quick Ratio of 0.84%, indicating strong ability to cover short-term liabilities.

Earnings analysis for Genprex Inc [GNPX]

With the latest financial reports released by the company, Genprex Inc posted -3/share EPS, while the average EPS was predicted by analysts to be reported at -2.3/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.7. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GNPX.

Insider trade positions for Genprex Inc [GNPX]

There are presently around $2.23%, or 2.24%% of GNPX stock, in the hands of institutional investors. The top three institutional holders of GNPX stocks are: ARMISTICE CAPITAL, LLC with ownership of 0.22 million shares, which is approximately 10.0834%. GEODE CAPITAL MANAGEMENT, LLC, holding 16497.0 shares of the stock with an approximate value of $$31103.0 in GNPX stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $$28869.0 in GNPX stock with ownership which is approximately 0.7084%.

The DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.